Clinical Trials in Pittsburgh

Showing 11901-11920 of 18,076 trials

Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)

NCT02537574

This study will evaluate the safety, effectiveness and tolerance of low doses of oral naltrexone along with buprenorphine to treat opioid use disorder prior to the first injection of VIVITROL.

Opioid Use Disorder

Alkermes, Inc.380 participantsStarted Aug 2015

Oceanside, California, United States • Orange, California, United States • Lauderhill, Florida, United States +17 more locations

COMPLETEDPhase 3< 1 mile

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral Therapy

NCT02607800

The primary objectives of this study are to compare the efficacy, safety, and tolerability of treatment with sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX) fixed dose combination (FDC) for 8 weeks with that of SOF/VEL FDC for 12 weeks in direct-acting antiviral-naive participants with chronic hepatitis C virus (HCV) infection.

Hepatitis C

Gilead Sciences943 participantsStarted Nov 2015

Long Beach, California, United States • Los Angeles, California, United States • Palo Alto, California, United States +90 more locations

Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral Therapy

Find Trials by Condition in Pittsburgh

The Mobile PTSD Coach App in Acute Injury Survivors

Eustachian Tube Testing in a Pressure Chamber -- Validation Study

Dose-Finding Study to Evaluate the Safety, Efficacy, & Tolerability of Multiple Doses of rAvPAL-PEG in Subjects With PKU

Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).

Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)

Model 4965 Post-Approval Study

A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid Tumors

Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD

Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years

Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data

Long-term Follow-up Study of Subjects Who Completed Clinical Studies 755.1100_FA, 810.1100_FA, or 1064.1100_FA

VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults

An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS)

Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine

Project LIFT - Promoting Healthy Behavior Through a Wearable Fitness Device and Financial Incentives

Safety and Dose Ranging Study of Samalizumab to Treat Relapsing or Refractory CLL or MM

Fresolimumab and Radiotherapy in Metastatic Breast Cancer

Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults